Home / Current Issue / Paper 1708995
Detection of Carbapenemase Genes Among Multi-Drug Resistant Klebsiella Pneumoniae from Clinical Specimens in Ibadan
Subject area: Biological & Medical Sciences · Area of research: Pharmaceutical Microbiology
Abstract
Carbapenem-resistant Klebsiella pneumoniae (CRKP) has become a serious public health concern as it can resist last-resort antibiotics, making treatment more challenging. This research examines the genetic characteristic of multidrug-resistant (MDR) K. pneumoniae obtained from clinical specimens in Ibadan tertiary facility clinics, particularly detecting carbapenem resistance genes. 156 clinical specimens, including sputum, wound swabs, and urine, were collected from selected healthcare facilities. Bacterial isolation and identification were performed using standard microbiological methods and antimicrobial susceptibility testing to assess resistance patterns. Molecular analysis was conducted using polymerase chain reaction (PCR) to detect genes responsible for carbapenem resistance, such as blaKPC, blaNDM, and blaVIM. Of the 156 clinical specimens examined, 52(33.8%) were positive for Klebsiella pneumoniae with the most significant proportion obtained from urine, 28(53.8%). The antimicrobial susceptibility testing revealed multi-drug resistance, with imipenem (98.1%), cefotaxime (90.4%), and cefuroxime (92.3%) among the most affected antibiotics. However, meropenem (69.2%) showed the highest susceptibility, suggesting potential differences in carbapenemase gene spread and expression. The average Multiple Antibiotic Resistance (MAR) index (0.85) obtained from AST assay further suggests strong antibiotic selection pressure among hospitals in this region, identifying the genetic factors driving carbapenem resistance. Molecular analysis via PCR assays confirmed the presence of carbapenemase genes, with bla_NDM (47%), bla_VIM, and bla_KPC identified in several isolates. The detection of these genes highlights the growing threat of carbapenem-resistant strains and suggests horizontal gene transfer as a potential mechanism for resistance spread. The widespread use and misuse of imipenem and meropenem may have contributed to the selection pressure driving this resistance. This study, however, emphasizes the pressing need for stronger antimicrobial stewardship, surveillance programs, and alternative treatment options to curb the spread of carbapenem-resistant bacteria in both clinical and public health environments.
Keywords
Resistance, Klebsiella pneumoniae, Carbapenemase, resistance genes(carbapenemase), Ibadan
References
[1] Akinyemi, K. O., Abegunrin, R. O., Iwalokun, B. A., Fakorede, C. O., Makarewicz, O., Neubauer, H., Pletz, M. W., & Wareth, G. (2021). The Emergence of Klebsiella pneumoniae with Reduced Susceptibility against Third Generation Cephalosporins and Carbapenems in Lagos Hospitals, Nigeria. Antibiotics, 10(2), 142. https://doi.org/10.3390/antibiotics10020142
[2] Ashurst, J. V., & Dawson, A. (2023,). Klebsiella pneumonia. StatPearls - NCBI Bookshelf. https://www.ncbi.nlm.nih.gov/books/NBK519004/
[3] Ayeni, R., Olley, M., Ibrahim, I., & Ashe, A. C. (2024b). Prevalence and Antibiotic Susceptibility Profile of Uropathogenic ESBL-producing Klebsiella pneumoniae in Keffi Metropolis, Nigeria. Asian Journal of Research in Infectious Diseases, 15(12), 1–15. https://doi.org/10.9734/ajrid/2024/v15i12396
[4] Echendu M. N., Ihenetu F. C, Chikwendu C. I., Nwabueze R. N. (2024). Prevalence of Klebsiella pneumoniae and Acinetobacter baumannii in Urine Samples of Pregnant Women in South-East, Nigeria. Microbiology Research Journal International, 34(5), 48–58. https://doi.org/10.9734/mrji/2024/v34i51446
[5] Effah, C. Y., Sun, T., Liu, S., and Wu, Y. (2020). Klebsiella pneumoniae: an increasing threat to public health. Annals of Clinical Microbiology and Antimicrobials, 19(1). https://doi.org/10.1186/s12941-019-0343-8
[6] Mohammed, Y., Zailani, S. B., & Onipede, A. O. (2015). Characterization of KPC, NDM and VIM Type Carbapenem Resistance <i>Enterobacteriaceae</i> from North Eastern, Nigeria. Journal of Biosciences and Medicines, 03(11), 100–107. https://doi.org/10.4236/jbm.2015.311013
[7] Nkup, J., Joseph, S., Agabi, Y., David, V., Hashimu, Z., Madubulum, C., David, A., Otobo, U., Goyil, G., Cirfat, N., Anejo-Okopi, J., & David, S. (2022b). Molecular detection of carbapenem resistant Klebsiella pneumoniae isolated from clinical specimens in Jos, Nigeria. Microbes and Infectious Diseases /Microbes and Infectious Diseases, 0(0), 0. https://doi.org/10.21608/mid.2022.145897.1329
[8] Okoche, D., Asiimwe, B. B., Katabazi, F. A., Kato, L., & Najjuka, C. F. (2015). Prevalence and Characterization of Carbapenem-Resistant Enterobacteriaceae Isolated from Mulago National Referral Hospital, Uganda. PLoS ONE, 10(8), e0135745. https://doi.org/10.1371/journal.pone.0135745
[9] <QRVjlstu‰ŠžŸ¶·¹ÇÈÉÓçèéêòôñåñÓñññññǼ¼°¼°¼°¼¼°°¡““‡xfR&hFÒh^~ 5�6�CJOJPJQJaJ"hFÒh^~ 5�6�CJOJQJaJh^~ hFÒCJOJQJaJh˜gCJOJQJaJhFÒhFÒ6�OJQJ]�hFÒhFÒ6�H*OJQJ]�hFÒhFÒH*OJQJhFÒhFÒOJQJh^~ CJ(OJQJaJ("hFÒhFÒ6�CJ(OJQJ]�aJ(hFÒCJ(OJQJaJ(hFÒhFÒCJ(OJQJaJ(tuÉèé껼%&;<Z[n!o!¯$õõõõççÝÝÝÌ´Ÿ••••• $¤a$gdg%Ô$„ñÿ„8dì¤:]„ñÿ^„8a$gdT$ &F„ñÿ„ÿdì¤:]„ñÿ`„ÿa$gdT$„ñÿdì¤:]„ñÿa$gdT $¤a$gdFÒ [Some characters in this reference could not be displayed correctly — please refer to the published PDF for the full reference.]
[10] „ñÿdð¤]„ñÿgdT $¤a$gdFÒôê êê꺻¼ÁÃÉË$%&-.:;<ììììììÛdzǡ�€€q_P>_"hTh˜g5�6�CJOJQJaJh˜gh^~ CJOJQJaJ"hThT5�6�CJOJQJaJhTCJOJQJ\�]�aJhT5�6�CJOJQJaJ"hFÒhT5�6�CJOJQJaJ"hFÒh^~ 5�6�CJOJQJaJ&hFÒhFÒ5�6�CJOJPJQJaJ&hFÒh^~ 5�6�CJOJPJQJaJ hFÒ5�6�CJOJPJQJaJ&hFÒhT5�6�CJOJPJQJaJhg%ÔhldCJaJhg%ÔhldCJOJQJaJhg%ÔhÙ?gCJOJQJaJhg%Ôh”I^CJOJQJaJhTCJOJQJaJhÙ?gCJOJQJaJhg%ÔhTCJOJQJaJ"hFÒhT6�CJOJQJ]�aJ6¯$°$¸$¹$Ï$ ''-'ï'ð'’*”*Ú*´5¶5¸5º56ý8þ8õàÒ½õõ½õõõõ½õõõõ¨õõ$ &F„„åþ¤^„`„åþa$gdÙ?g$ &F„„äþ¤^„`„äþa$gdÙ?g [Some characters in this reference could not be displayed correctly — please refer to the published PDF for the full reference.]
How to cite this paper
@article{1708995,
author = {Olamide S. Olowoyeye, Hammed O. Bisiriyu, Mojirayo T. Durowaiye, Joy D. Ajiboye},
title = {Detection of Carbapenemase Genes Among Multi-Drug Resistant Klebsiella Pneumoniae from Clinical Specimens in Ibadan},
journal = {Iconic Research And Engineering Journals},
year = {2025},
volume = {8},
number = {12},
pages = {252-259},
issn = {2456-8880},
url = {https://www.irejournals.com/formatedpaper/1708995.pdf},
abstract = {Carbapenem-resistant Klebsiella pneumoniae (CRKP) has become a serious public health concern as it can resist last-resort antibiotics, making treatment more challenging. This research examines the genetic characteristic of multidrug-resistant (MDR) K. pneumoniae obtained from clinical specimens in Ibadan tertiary facility clinics, particularly detecting carbapenem resistance genes. 156 clinical specimens, including sputum, wound swabs, and urine, were collected from selected healthcare facilities. Bacterial isolation and identification were performed using standard microbiological methods and antimicrobial susceptibility testing to assess resistance patterns. Molecular analysis was conducted using polymerase chain reaction (PCR) to detect genes responsible for carbapenem resistance, such as blaKPC, blaNDM, and blaVIM. Of the 156 clinical specimens examined, 52(33.8%) were positive for Klebsiella pneumoniae with the most significant proportion obtained from urine, 28(53.8%). The antimicrobial susceptibility testing revealed multi-drug resistance, with imipenem (98.1%), cefotaxime (90.4%), and cefuroxime (92.3%) among the most affected antibiotics. However, meropenem (69.2%) showed the highest susceptibility, suggesting potential differences in carbapenemase gene spread and expression. The average Multiple Antibiotic Resistance (MAR) index (0.85) obtained from AST assay further suggests strong antibiotic selection pressure among hospitals in this region, identifying the genetic factors driving carbapenem resistance. Molecular analysis via PCR assays confirmed the presence of carbapenemase genes, with bla_NDM (47%), bla_VIM, and bla_KPC identified in several isolates. The detection of these genes highlights the growing threat of carbapenem-resistant strains and suggests horizontal gene transfer as a potential mechanism for resistance spread. The widespread use and misuse of imipenem and meropenem may have contributed to the selection pressure driving this resistance. This study, however, emphasizes the pressing need for stronger antimicrobial stewardship, surveillance programs, and alternative treatment options to curb the spread of carbapenem-resistant bacteria in both clinical and public health environments.},
keywords = {Resistance, Klebsiella pneumoniae, Carbapenemase, resistance genes(carbapenemase), Ibadan},
month = {June},
}